<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-SABNTD1D</identifier><date>2004</date><creator>Borin, Peter</creator><creator>Glaser, Marjana</creator><creator>Grmek-Zemljič, Tatjana</creator><relation>documents/doc/S/URN_NBN_SI_doc-SABNTD1D_001.pdf</relation><relation>documents/doc/S/URN_NBN_SI_doc-SABNTD1D_001.txt</relation><format format_type="issue">4</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 207-210</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">1527871</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-SABNTD1D</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">Leukemia, myeloid, chronic</subject><subject language_type_id="slv">Levkemia, mieloična, kronična</subject><subject language_type_id="slv">Protein-tirozin kinaza</subject><subject language_type_id="slv">Protein-tyrosine kinase</subject><subject language_type_id="slv">Therapy</subject><subject language_type_id="slv">Zdravljenje</subject><title>Naše izkušnje pri zdravljenju kronične mieloične levkemije z imatinib mesilatom</title><title>Our experience in treatment of chronic myeloid leukemia with imatinib mesylate</title></Record>